Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03393819Completed
Randomised, open-label trial in surgical site infection (SSI) comparing Duraprep with Chloraprep (2 arms). Primary endpoint: Positive culture rates of residual bacteria following surgical skin preparation. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03393819.